Evidence map›Paper›PMID 20560208›Full record

ArticleAmerican journal of human genetics2010

Powerful SNP-set analysis for case-control genome-wide association studies.

Michael C Wu, Peter Kraft, Michael P Epstein, Deanne M Taylor, Stephen J Chanock, David J Hunter, Xihong Lin

Abstract read
In one paragraph

Article in American journal of human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 379 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
379citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

379 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

319 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael C WuDepartment of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Peter Kraft
Michael P Epstein
Deanne M Taylor
Stephen J Chanock
David J Hunter
Xihong Lin

Funding

GRADUATE TRAINING IN BIOSTATISTICST32ES007142 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Brent Andrew Coull · 1985 to 2026
$11.9M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Statistical Methods for the Spatio-Temporal Assessment of Social Disparities in CancerP01CA134294 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANEUSE, SEBASTIEN, HERNAN, MIGUEL · 2008 to 2017
$6.8M
Statistical Methods for Correlated and High-Dimensional Biomedical DataR37CA076404 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIN, XIHONG · 2007 to 2014
$2.5M
Novel Statistical Methods for Human Gene MappingR01HG003618 · NHGRI · EMORY UNIVERSITY · PI EPSTEIN, MICHAEL PHILIP · 2006 to 2010
$1.5M
Statistical Methods for Correlated Biomedical DataR01CA076404 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIN, XIHONG · 2003 to 2006
$1.1M
NEW MIXED EFFECTS MODELS FOR CORRELATED BIOMEDICAL DATAR29CA076404 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIN, XIHONG · 1998 to 2002
$314k
NCI NIH HHS CA134294NCI NIH HHS CA76404NCI NIH HHS P01 CA134294NCI NIH HHS R01 CA076404NCI NIH HHS R29 CA076404NCI NIH HHS R35 CA197449NCI NIH HHS R37 CA076404NHGRI NIH HHS HG003618NHGRI NIH HHS R01 HG003618NIEHS NIH HHS T32 ES007142
6 · The paper itself

Abstract

GWAS have emerged as popular tools for identifying genetic variants that are associated with disease risk. Standard analysis of a case-control GWAS involves assessing the association between each individual genotyped SNP and disease risk. However, this approach suffers from limited reproducibility and difficulties in detecting multi-SNP and epistatic effects. As an alternative analytical strategy, we propose grouping SNPs together into SNP sets on the basis of proximity to genomic features such as genes or haplotype blocks, then testing the joint effect of each SNP set. Testing of each SNP set proceeds via the logistic kernel-machine-based test, which is based on a statistical framework that allows for flexible modeling of epistatic and nonlinear SNP effects. This flexibility and the ability to naturally adjust for covariate effects are important features of our test that make it appealing in comparison to individual SNP tests and existing multimarker tests. Using simulated data based on the International HapMap Project, we show that SNP-set testing can have improved power over standard individual-SNP analysis under a wide range of settings. In particular, we find that our approach has higher power than individual-SNP analysis when the median correlation between the disease-susceptibility variant and the genotyped SNPs is moderate to high. When the correlation is low, both individual-SNP analysis and the SNP-set analysis tend to have low power. We apply SNP-set analysis to analyze the Cancer Genetic Markers of Susceptibility (CGEMS) breast cancer GWAS discovery-phase data.

Indexed as

Polymorphism, Single NucleotideBreast NeoplasmsGenetic MarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansStatistics as TopicGenetic Markers

Identifiers

PMID20560208
PMCPMC3032061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.